<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
SRPT
Sarepta
$
()


  • PepGen price target lowered by $1 at Wedbush, here's why

    3/7/2024 - 08:17am
  • Sarepta price target raised by $3 at UBS, here's why

    3/1/2024 - 07:19am
  • Sarepta price target raised by $6 at RBC Capital, here's why

    2/29/2024 - 08:29am
  • Sarepta price target raised by $12 at Citi, here's why

    2/29/2024 - 06:18am
  • Sarepta price target raised by $44 at Barclays, here's why

    2/29/2024 - 06:12am
  • Sarepta reports Q4 EPS 82c, consensus 1c

    2/28/2024 - 16:29pm
  • Sarepta price target raised by $30 at TD Cowen, here's why

    2/20/2024 - 07:15am
  • Sarepta price target raised by $5 at BofA, here's why

    2/16/2024 - 17:20pm
  • Sarepta Priority Review confirms FDA 'amenability to approval,' says RBC Capital

    2/16/2024 - 10:08am
  • Sarepta announces FDA acceptance of efficacy supplement to Elevidys BLA

    2/16/2024 - 07:15am
  • Sarepta price target raised by $15 at Mizuho, here's why

    2/14/2024 - 06:42am
  • Sarepta price target raised by $47 at Citi, here's why

    2/5/2024 - 10:05am
  • UPS downgraded, Stryker upgraded: Wall Street's top analyst calls

    1/31/2024 - 09:53am
  • Sarepta initiated with bullish view at BMO Capital, here's why

    1/31/2024 - 04:28am
  • Catalent price target raised by $3 at RBC Capital, here's why

    1/30/2024 - 09:37am
dynamic_feed Breaking News